NeuBase Therapeutics - 53 Year Dividend History | NBSE

Historical dividend payout and yield for NeuBase Therapeutics (NBSE) since 1971. The current TTM dividend payout for NeuBase Therapeutics (NBSE) as of May 10, 2024 is $0.00. The current dividend yield for NeuBase Therapeutics as of May 10, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.001B $0.000B
NeuBase Therapeutics Inc. is a biotechnology company. It is engaged in developing antisense therapies to address genetic diseases. The company's proprietary platform includes PATrOL(TM). NeuBase Therapeutics Inc., formerly known as Ohr Pharmaceutical Inc., is based in Pittsburgh, United States.
Stock Name Country Market Cap PE Ratio